2022 Annual Conference   |  February 23-25, 2022   |  Salt Lake City, Utah, USA

This event will be in-person in Salt Lake City, Utah (with some online elements for those unable to travel)

Meet our 2022 Annual Conference Co-Chairs


Jesper Andersen, PhD

Associate Professor & Group Leader,
Andersen Group
Biotech Research and Innovation Centre (BRIC)
Department of Health and Medical Sciences
University of Copenhagen

Copenhagen, Denmark


Lipika Goyal, MD, MPhil

Assistant Professor
Lead of the Liver Cancer Research Program
Harvard Medical School
Massachusetts General Hospital Cancer Center

Boston, Massachusetts, USA



We are closely following the latest COVID-19 developments, particularly the increased caseloads from the Delta variant. We think empirical data and the best available projections mean we can offer a safe, in-person conference in Salt Lake City. To help manage the safety of all, attendees must be fully vaccinated for COVID-19 and be masked. We are adhering to local safety guidelines and regulations. For the latest information on requirements for Salt Lake City, click HERE.

If you are unable to join us in person, we welcome and encourage you to attend the conference virtually. Regardless of how you attend, register now.

2021 Conference by the Numbers

  • 1,647 Registered
  • 54% Patients & Caregivers
  • 31% Clinicians & Researchers
  • 15% Industry Representatives & Sponsors
  • 52 Countries Represented
  • 50 States, DC & Puerto Rico

Who Should Attend?

Who Should Attend?

  • Researchers
  • Physicians
  • Oncologists
  • Radiologists
  • Surgeons

  • Gastroenterologists
  • Hepatologists
  • Nurses specializing in oncology, intensive care, and palliative care
  • Pharmaceutical Companies

  • Government Regulators
  • Policymakers
  • Patients, Caregivers and others invested in the field of cholangiocarcinoma